Express Scripts Inc. - Conference Presentation Calls

Express Scripts Inc. reports unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the third quarter, the company reported the revenues of $5,619.4 million, operating income of $358.5 million, income before income taxes of $312.5 million, net income from continuing operations of $196.9 million, net income of $197.6 million, diluted earnings per share from continuing operations of $0.71, and diluted net earnings per share of $0.71as compared to revenues of $5,450.5 million, operating income of $330.7 million, income before income taxes of $315.1 million, net income from continuing operations of $203.0 million, net income of $201.9 million, diluted earnings per share from continuing operations of $0.81, and diluted net earnings per share of $0.81for the same period a year ago. Adjusted EBITDA from continuing operations of $426.9 million or adjusted EBITDA per adjusted claim of $3.38 as compared to the adjusted EBITDA from continuing operations of $354.0 million or adjusted EBITDA per adjusted claim of $2.87 for the same period a year ago. Adjusted EPS from continuing operations of $0.81 as compared to the adjusted EPS from continuing operations of $0.81for the same period a year ago. For the nine months, the company reported the revenues of $16,545.5 million, operating income of $1,094.0 million, income before income taxes of $955.4 million, net income from continuing operations of $603.6 million, net income of $604.3 million, diluted earnings per share from continuing operations of $2.30, and diluted net earnings per share of $2.31 as compared to the revenues of $16,472.1 million, operating income of $942.0 million, income before income taxes of $894.4 million, net income from continuing operations of $573.3 million, net income of $569.3 million, diluted earnings per share from continuing operations of $2.27, and diluted net earnings per share of $2.25 for the same period a year ago. Net cash provided by operating activities from continuing operations of $913.4 million, net cash flows provided by operating activities of $926.5 million and purchases of property and equipment of $90.5 million as compared to the net cash provided by operating activities from continuing operations of $727.1 million, net cash flows provided by operating activities of $729.0 million and purchases of property and equipment of $59.9 million for the same period a year ago. Adjusted EBITDA from continuing operations of $1,208.8 million or adjusted EBITDA per adjusted claim of $3.21 as compared to the adjusted EBITDA from continuing operations of $1,014.9 million or adjusted EBITDA per adjusted claim of $2.66 for the same period a year ago. Adjusted EPS from continuing operations of $2.54 as compared to the adjusted EPS from continuing operations of $2.27 for the same period a year ago. The company revised earnings guidance for the full year of 2009. For the full year of 2009, the company previously provided 2009 earnings per diluted share guidance in a range of $3.72 to $3.82, which excluded any impact related to the NextRx transaction. Due to strong underlying fundamentals in the core business, the company now believes 2009 earnings on the same basis will be in a range of $3.76 to $3.82, representing 21% to 23% growth over 2008.

Express Scripts Inc. expected to Report Fiscal Year 2009 Results on February 22, 2010. This event was calculated by Capital IQ (Created on October 28, 2009).